Dimensional Fund Advisors LP Has $273.06 Million Stake in Corteva, Inc. (NYSE:CTVA)

Dimensional Fund Advisors LP grew its position in Corteva, Inc. (NYSE:CTVA) by 2.2% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,794,086 shares of the company’s stock after purchasing an additional 102,109 shares during the period. Dimensional Fund Advisors LP’s holdings in Corteva were worth $273,062,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in the company. Independent Franchise Partners LLP raised its holdings in shares of Corteva by 51.5% in the fourth quarter. Independent Franchise Partners LLP now owns 16,496,508 shares of the company’s stock valued at $939,641,000 after buying an additional 5,604,838 shares during the last quarter. Norges Bank acquired a new position in Corteva during the 4th quarter worth $251,892,000. Raymond James Financial Inc. acquired a new stake in shares of Corteva in the 4th quarter valued at $161,052,000. Franklin Resources Inc. lifted its stake in shares of Corteva by 9.2% during the fourth quarter. Franklin Resources Inc. now owns 16,143,025 shares of the company’s stock valued at $919,507,000 after acquiring an additional 1,354,418 shares during the period. Finally, B. Metzler seel. Sohn & Co. AG increased its position in Corteva by 69.0% in the fourth quarter. B. Metzler seel. Sohn & Co. AG now owns 2,870,859 shares of the company’s stock worth $163,181,000 after purchasing an additional 1,172,110 shares during the period. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Stock Performance

Shares of CTVA opened at $59.21 on Tuesday. The stock has a market capitalization of $40.44 billion, a price-to-earnings ratio of 45.90, a PEG ratio of 1.68 and a beta of 0.73. Corteva, Inc. has a 12 month low of $50.01 and a 12 month high of $66.24. The firm has a fifty day simple moving average of $60.92 and a 200 day simple moving average of $60.31. The company has a current ratio of 1.45, a quick ratio of 0.93 and a debt-to-equity ratio of 0.08.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.32 EPS for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. Research analysts forecast that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 3rd were issued a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 1.15%. The ex-dividend date of this dividend was Monday, March 3rd. Corteva’s payout ratio is presently 52.71%.

Insider Activity at Corteva

In related news, insider Brian Titus sold 26,560 shares of the firm’s stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $63.74, for a total value of $1,692,934.40. Following the completion of the sale, the insider now directly owns 11,347 shares in the company, valued at approximately $723,257.78. This trade represents a 70.07 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.14% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. Bank of America lifted their price target on shares of Corteva from $69.00 to $73.00 and gave the stock a “buy” rating in a research report on Tuesday, February 11th. UBS Group decreased their price objective on Corteva from $74.00 to $73.00 and set a “buy” rating for the company in a research note on Friday, January 10th. BNP Paribas upgraded Corteva to a “hold” rating in a research report on Monday, February 10th. Oppenheimer lifted their price objective on shares of Corteva from $70.00 to $72.00 and gave the stock an “outperform” rating in a research note on Friday, February 7th. Finally, The Goldman Sachs Group assumed coverage on shares of Corteva in a research note on Thursday, March 13th. They issued a “buy” rating and a $71.00 target price for the company. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat.com, Corteva has a consensus rating of “Moderate Buy” and a consensus target price of $68.13.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.